ARCHIVES

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

Kimes Calls Headline On DRG ‘Exaggerated Negativity’ In Letter

April 5, 1991

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010